Nicholas Delatorre

Nicholas Delatorre is a skilled Senior Scientist specializing in CMC at Third Arc Bio since January 2025, following a previous role as Scientist II at Asimov from September 2021 to January 2025. During tenure at Asimov, Nicholas developed CHO cell culture processes and presented research at Cell UK. Prior experience includes positions at Biogen, where Nicholas improved bioprocessing methods for monoclonal antibodies, and Lyndra Therapeutics, focusing on biodegradable materials for drug delivery systems. Nicholas has also contributed to research at Northeastern University and various internships, acquiring extensive knowledge in biopharmaceutical development, process optimization, and innovative project management throughout a career that began with a Bachelor of Science in Chemical Engineering from Northeastern University in 2017.